Nanoviricides, Inc. (NNVC): EPS (Diluted)
-$0.63
Year ended 2025-06-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | -$0.63 | n/m | 2025-09-29, From 2024-07-01 |
| 2024-06-30 | -$0.70 | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$0.74 | n/m | 2024-09-27, From 2022-07-01 |
| 2022-06-30 | -$0.70 | n/m | 2023-10-13, From 2021-07-01 |
| 2021-06-30 | -$0.81 | n/a | 2022-10-13, From 2020-07-01 |
| No annual figure between 2018-06-30 and 2021-06-30. | |||
| 2018-06-30 | -$0.13 | n/m | 2018-10-12, From 2017-07-01 |
| 2017-06-30 | -$0.17 | n/m | 2018-10-12, From 2016-07-01 |
| 2016-06-30 | -$0.19 | n/m | 2018-10-12, From 2015-07-01 |
| 2015-06-30 | -$0.09 | n/m | 2017-09-28, From 2014-07-01 |
| 2014-06-30 | -$0.27 | n/m | 2016-09-16, From 2013-07-01 |
| 2013-06-30 | -$0.19 | n/a | 2015-09-14, From 2012-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | -$0.63 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.72 | -51.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.46 | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$0.05 | n/m |
| Eli Lilly & Co (LLY) | 2025-12-31 | $22.95 | +96.0% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.36 | -3.5% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.03 | +90.5% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.28 | +8.0% |
Compare NNVC, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗